{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T15:51:17Z","timestamp":1753890677087,"version":"3.41.2"},"reference-count":13,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,8,10]],"date-time":"2022-08-10T00:00:00Z","timestamp":1660089600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:p>A 39-year-old-woman with a past medical history of type 2 diabetes mellitus (T2DM) on oral hypoglycemic agents presented to the emergency room with nausea, vomiting, shortness of breath, and altered mental status. Seven days prior to presentation, she was diagnosed with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. Laboratory workup on presentation confirmed the diagnosis of diabetic ketoacidosis (DKA) (blood glucose 523 mg\/dl, beta-hydroxybutyrate 8.91 mmol\/l, pH 6.9, bicarbonate 11 mEq\/l, anion gap 25 mEq\/l, and HbA1c 10.8%). She was managed for DKA with hydration and insulin drip and discharged home. However, to our surprise, at the 2-week follow-up visit, she was found to have positive antibodies for zinc transporter 8 (ZnT8) (samples were collected on day of presentation). The rest of her antibodies associated with T1DM were negative. She was therefore started on a basal-bolus regimen and managed as type 1 diabetes mellitus (T1DM). Our case illustrates that there is an increased risk of T1DM following infection with SARS-CoV-2.<\/jats:p>","DOI":"10.3389\/fendo.2022.983206","type":"journal-article","created":{"date-parts":[[2022,8,24]],"date-time":"2022-08-24T10:06:11Z","timestamp":1661335571000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":3,"title":["Case report: SARS-CoV-2 infection as a trigger for diabetic ketoacidosis and newly detected pancreatic autoantibodies"],"prefix":"10.3389","volume":"13","author":[{"given":"Rahul","family":"Mishra","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ghada","family":"Elshimy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lakshmi","family":"Kannan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aasems","family":"Jacob","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rishi","family":"Raj","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2022,8,10]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21145145","article-title":"COVID-19: A review on diagnosis, treatment, and prophylaxis","volume":"21","author":"Fierabracci","year":"2020","journal-title":"Int J Mol Sci"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2020.102597","article-title":"Covid-19 and autoimmunity","volume":"19","author":"Ehrenfeld","year":"2020","journal-title":"Autoimmun Rev"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.2174\/156652409789839134","article-title":"Unravelling the role of infectious agents in the pathogenesis of human autoimmunity: the hypothesis of the retroviral involvement revisited","volume":"9","author":"Fierabracci","year":"2009","journal-title":"Curr Mol Med"},{"key":"B4","doi-asserted-by":"publisher","first-page":"59","DOI":"10.15585\/mmwr.mm7102e2","article-title":"Risk for newly diagnosed diabetes >30 days after SARS-CoV-2 infection among persons aged <18 years \u2014 united states","volume":"2022","author":"Barrett","year":"2020","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.3390\/medicina57090973","article-title":"Increased incidence of type 1 diabetes during the COVID-19 pandemic in Romanian children","volume":"57","author":"Vlad","year":"2021","journal-title":"Medicina (Kaunas)"},{"key":"B6","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/s0002-9343(96)00076-9","article-title":"The occurrence of diabetic ketoacidosis in non-insulin-dependent diabetes and newly diagnosed diabetic adults","volume":"101","author":"Westphal","year":"1996","journal-title":"Am J Med"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1111\/j.1464-5491.2005.01660.x","article-title":"Pathophysiology of ketoacidosis in type 2 diabetes mellitus","volume":"22","author":"Linfoot","year":"2005","journal-title":"Diabetes Med"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2015.12.007","article-title":"The evolution of diabetic ketoacidosis: An update of its etiology, pathogenesis and management","volume":"65","author":"Nyenwe","year":"2016","journal-title":"Metabolism: Clin experimental"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2020.154301","article-title":"Letter to the editor: Unexpected high mortality in COVID-19 and diabetic ketoacidosis","volume":"110","author":"Chamorro-Pareja","year":"2020","journal-title":"Metabolism: Clin experimental"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0705894104","article-title":"The cation efflux transporter ZnT8 (Slc30A8) is a major autoantigen in human type 1 diabetes","volume":"104","author":"Wenzlau","year":"2007","journal-title":"Proc Natl Acad Sci USA"},{"key":"B11","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/s13052-022-01226-5","article-title":"SARS-CoV-2 infection as possible downstream disease precipitator in autoantibody-positive insulin-dependent diabetes mellitus: a case report","volume":"48","author":"Schiaffini","year":"2022","journal-title":"Ital J Pediatr"},{"key":"B12","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.1016\/j.cmet.2021.05.013","article-title":"SARS-CoV-2 infects human pancreatic \u03b2 cells and elicits \u03b2 cell impairment","volume":"33","author":"Wu","year":"2021","journal-title":"Cell Metab"},{"key":"B13","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.stem.2020.06.015","article-title":"A human pluripotent stem cell-based platform to study SARS-CoV-2 tropism and model virus infection in human cells and organoids","volume":"27","author":"Yang","year":"2020","journal-title":"Cell Stem Cell"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2022.983206\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,24]],"date-time":"2022-08-24T10:06:12Z","timestamp":1661335572000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2022.983206\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,10]]},"references-count":13,"alternative-id":["10.3389\/fendo.2022.983206"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2022.983206","relation":{},"ISSN":["1664-2392"],"issn-type":[{"type":"electronic","value":"1664-2392"}],"subject":[],"published":{"date-parts":[[2022,8,10]]},"article-number":"983206"}}